Results 221 to 230 of about 59,251 (307)

Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

JACC Adv
Kido K, Hashiguchi M, Guglin M.
europepmc   +1 more source

Real-life Effectiveness and Safety of Amlodipine/Valsartan Single-pill Combination in Patients with Hypertension in Egypt: Results from the EXCITE Study [PDF]

, 2016
Samir H. Assaad‐Khalil, Nashwa Nashaat
openalex   +1 more source

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients. [PDF]

Biomed Rep
Rampengan DDCH, Surya SC, Tjandra KC, Lele JAJMN, Rampengan SH, Kadariswantiningsih IN, Idrisov B, Idrisova A, Empitu MA.   +8 more
europepmc   +1 more source

A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Wang S, Lai J, Chen J, Luo Q, Yi W, Lai Y.   +5 more
europepmc   +1 more source

Cytotoxic Effects of Valsartan Organotin(IV) Complexes on Human Lung Cancer Cells

, 2020
Alaa Mohammed, Raghda S. Makia, Muataz Ali, Rasha Raheem, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, M Pereyre, J Quintard, A Rahm, Y Ellahioui, S Prashar, S Gmez-Ruiz, J Devi, J Yadav, L Hunakova, E Horvathova, K Majerova, P Bobal, J Otevrel, J Brtko, J Adeyemi, D Onwudiwe, A Ekennia, C Anokwuru, N Nundkumar, M Singh, C Hosten, E, W Rehman, A Badshah, F Rahim, M Baloch, H Ullah, O Abid, M Nawaz, I Tauseef, S Ali, S Shahzadi, D Imtiaz-Ud, W Rom, K Tchou-Wong, E Ventura, A Giordano, L Corea, O Cardoni, R Fogari, P Innocenti, C Porcellati, M Provvidenza, S Meilenbrock, J Sullivan, F Bodin, Valsartan, I Abraham, K Macdonald, C Hermans, A Aerts, C Lee, H Bri, S Vancayzeele, I Dadzie, S Avorgbedo, R Appiah-Opong, O Cudjoe, M Gorry, T Yoneyama, L Vujanovic, M Moss, M Garlin, M Miller, J Herman, L Stabile, N Vujanovic, A Mohammed, G El-Hiti, E Yousif, A Ahmed, D Ahmed, M Alotaibi, M Nikbakht, B Pakbin, G Brujeni, R Kumari, R Mishra, J Yadav, G Bai, T Matsuba, H Kikuchi, H Chagan-Yasutan, H Motoda, R Ozuru, O Yamada, Y Oshima, T Hattori, F Shaheen, S Ali, S Shahzadi, Synthesis, H Ullah, V Previtali, H Mihigo   +99 more
openalex   +1 more source

Antihypertensive drugs for hyperuricemia in patients with hypertension: a systematic review and network meta-analysis of Chinese trials. [PDF]

BMC Cardiovasc Disord
Wu J, Di H, Zhang Y, Zeng X.
europepmc   +1 more source

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF. [PDF]

Eur Heart J Cardiovasc Pharmacother
Yang M, Henderson AD, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Rouleau JL, Swedberg K, Vaduganathan M, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Rizkala A, Lewis EF, Jhund PS, Solomon SD, McMurray JJV.   +18 more
europepmc   +1 more source

Sacubitril/Valsartan Conundrum

Cardiology Research, 2021
openaire   +3 more sources

A sensitive green HPLC-fluorescence method for simultaneous analysis of sacubitril and valsartan in pure forms, pharmaceutical dosage form and human plasma. [PDF]

Sci Rep
Kormod LA, Hegazy MA, Kessiba AM.
europepmc   +1 more source

Cardiovascular disease and adult healing cells: From bench top to bedside [PDF]

, 2017
Black Jr., Asa C, Black, Gypsy F., Coleman, Julie, Hawkins, Kristina C, Lachner, Frank, Limnios, Jason Ionnis, McCommon, George, Williams, Shanna, Young, Henry E.   +8 more
core   +1 more source